Comparison of the Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Stent for Coronary Lesions in Acute Myocardial Infarction.

Trial Profile

Comparison of the Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Stent for Coronary Lesions in Acute Myocardial Infarction.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2014

At a glance

  • Drugs Everolimus (Primary) ; Zotarolimus (Primary)
  • Indications Coronary artery restenosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms EVERZOTA
  • Most Recent Events

    • 06 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top